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ABSTRACT
Objective: An efficient and selective analytical method with precolumn derivatization using reverse-phase high-performance liquid chromatography 
(RP-HPLC) was developed for the analysis of tranexamic acid in whitening creams.
Methods: Derivatization was performed using 1% ninhydrin solution in methanol as a derivation agent to form a colored Ruhemann’s purple product. 
The analytical conditions included the use of a C18 column as the stationary phase and a methanol: acetate (20 mM) buffer at pH 4 (75:25) as the 
mobile phase, with a flow rate of 0.8 mL/min and UV–visible detection at a wavelength of 570 nm.
Results: The average retention time of the tranexamic acid derivative was 5.413 min. The results of the calibration curves were linear, with a 
correlation coefficient (r) of 0.9993 at a concentration ranging from 8 to 48 μg/mL. The recovery was between 99.26% and 101.77%. The limits of 
detection and quantification were 1.87 μg/mL and 6.25 μg/mL, respectively.
Conclusion: The analytical method developed in this study met the validation requirements and included a simple and efficient derivatization method 
applicable for the selective analysis of tranexamic acid in whitening creams.
Keywords: Derivatization, Reverse-phase high-performance liquid chromatography, Ninhydrin, Optimization, Tranexamic acid, Validation, Whitening cream.
INTRODUCTION
Tranexamic acid, or trans-4-(aminomethyl)cyclohexanecarboxylic 
acid (Fig. 1), is an antifibrinolytic drug that works by inhibiting the 
activation of plasminogen into plasmin [1]. In the cosmetic industry, 
tranexamic acid is also used as an ingredient in whitening creams at a 
maximum concentration range of 1.5–2% [2]. However, the excessive 
use of tranexamic acid on the skin can cause local toxicity, including 
irritation and allergies [3]. Therefore, the presence of tranexamic acid 
in whitening cream preparations should be considered so that the 
concentration does not exceed the specified limit.
Because tranexamic acid does not have a chromophore group, it cannot 
be measured with a UV–visible detector and requires a derivatization 
process to increase its detection sensitivity [4]. The previous 
studies on the derivatization of tranexamic acid reported the use of 
various derivative agents, such as 0.2% ninhydrin in methanol [5], 
phenyl isothiocyanate [6], 2-hydroxynaphthaldehyde in ethanol [7], 
sodium picryl sulfonate [8], benzene sulfonyl chloride [4], and 
2,4-dinitrofluorobenzene [9].
However, among these studies, none analyzed for tranexamic acid in 
cream preparations because they typically only used the drug tablets 
or biological fluids as samples. Therefore, in this study, we aimed to 
optimize and validate an analytical method for detecting tranexamic 
acid in whitening creams using reverse-phase high-performance liquid 
chromatography (RP-HPLC) with precolumn derivatization.
MATERIALS AND METHODS
Instrumentation
HPLC (LC 20AT, Shimadzu, Japan) equipped with pump, SunFireTM C18 
column, UV-VIS detector SPD-10A (Shimadzu, Japan), manual injector, 
and data processor (LC-Solution), UV-Vis Spectrophotometry (Jasco 
V-530), syringe HPLC (SGE, Australia), centrifuge (Labofuge 5100), 
vortex (Thermo Scientific), micropipette (Eppendorf), sonicator 
ultrasonic, hotplate (IKA® C-MAG HS 7), pH meters (Eutech Instruments 
pH 510), and Whatman filter membrane diameter 0.45.
Chemicals and reagents
Tranexamic acid (Hunan Dongting Pharmaceutical Co., Ltd.), acetonitrile 
and methanol HPLC grade (Merck), ninhydrin (Merck), acetic glacial 
acid (Merck), ammonium acetate (Mallinckrodt AR®), distilled water 
(Ikapharmindo), and whitening cream samples from the market.
Chromatography condition
Chromatographic separation was carried out using a C18 column as the 
stationary phase and a methanol-acetate (20 mM) buffer at pH 4 (75:25) 
as the mobile phase, with a flow rate of 0.8 mL/min. Chromatographic 
detection using the UV–visible detector was performed at a wavelength 
of 570 nm.
Standard and working solution preparation
The standard stock solution of tranexamic acid (1000 μg/mL) was 
prepared by dissolving 100 mg of tranexamic acid into a 100 mL 
volumetric flask containing 70 mL of solvent (methanol-aquadest, 
90:10, v/v). The mixture was sonicated for 15 min and then the volume 
was brought up to the final mark with solvent. The working solution 
was prepared by diluting the standard stock solution with solvent until 
a working solution of 200 μg/mL tranexamic acid was obtained. This 
working solution was then filtered through a 0.45 μm membrane filter 
and stored in the refrigerator until further analysis.
Derivatization was performed by mixing 1 mL of working solution with 
1% ninhydrin in methanol. The mixture was warmed in a constant 
temperature bath. The derivatization process was optimized by 
varying the reaction time, temperature of the reaction, and the ratio 
between tranexamic acid and ninhydrin. The reaction times were 15, 
20, and 30 min, the temperatures were 70, 80, 90, and 100°C, and 
the volumes of ninhydrin were 1 and 2 mL. After the derivatization 
process was finished, 1 mL of the finished mixture was transferred into 
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a 5 mL volumetric flask and the volume was brought up to the mark 
with distilled water until a concentration of 40 μg/mL tranexamic acid 
derivative was obtained. Derivatization of the working solution was 
done individually before HPLC analysis.
Sample preparation
Fifty milligrams of the cream sample were accurately weighed and 
transferred to an Erlenmeyer flask. Five milliliters of solvent were then 
added to the flask and the solution was heated in an 80°C water bath 
for 1–2 min while shaking vigorously until the cream was completely 
dissolved. The mixture was then vortexed for 1 min followed by 
centrifugation at 4000 rpm for 15 min. The supernatant was then 
filtered through a 0.45 µm membrane filter. A 2 mL aliquot was then 
derivatized using the selected optimal conditions and further diluted 
to obtain a final working concentration. Twenty microliters of the final 
sample were then injected into the HPLC system and the chromatogram 
was recorded.
System suitability test
Twenty microliters of the tranexamic acid derivate were injected into 
the HPLC system using optimal analysis conditions. The injections were 
repeated 6 times to ensure a constant peak area. The results of each 
trial were recorded and the coefficient of variation (CV) was calculated 
(% CV). The % CV value should be ≤ 2%. The parameters were based 
on the separation between two adjacent peaks (R), tailing factor, 
retention time, column efficiency (height equivalent to a theoretical 
plate [HETP]), and the number of theoretical plates (N).
Validation method
This method was validated using specific parameters, including 
selectivity, linearity, limit of detection (LOD), limit of quantification 
(LOQ), accuracy, and precision. Selectivity was carried out by comparing 
the chromatogram of a placebo solution with the standard solution 
around the retention time of the tranexamic acid derivative. There 
should be no interference with the chromatogram of the placebo/blank 
solution. The linearity of the method was determined with standard 
solutions using six concentration points in the range of 8–48 μg/
mL. The concentration was obtained by diluting a standard solution 
of 200 μg/mL tranexamic acid derivative. The calibration curve was 
plotted between the relationship between the concentration and the 
area using the least square method. The LOD and LOQ were calculated 
using statistical calculations with a linear regression calibration curve 
using the Sb value, which is equal to the residual standard deviation 
(RSD) (S y⁄x).
Accuracy and precision were examined using a simulation or spiked 
placebo recovery method. We weighed a number of cream matrixes for 
each concentration of 80%, 100%, and 120%, using 62.5 mg, 50 mg, and 
41.7 mg, respectively. At each concentration, 5 mL of a standard solution 
of 200 µg/mL tranexamic acid were added and then the preparation 
and derivatization were carried out using the same methods as for 
the preparation of the cream sample. Accuracy was calculated based 
on the percentage of recovery, while the precision was calculated by 
the percentage of the RSD based on three injections at concentrations 
of 80% and 120% and six injections at a concentration of 100%. The 
percentage of recovery was 98–102%, indicating that the method was 




In this study, the derivatization process was performed using ninhydrin, 
which reacts specifically with the primary amine group of tranexamic 
acid in the range of pH 5–7 [10]. At the molecular level, two ninhydrin 
molecules will react with one amine molecule in an organic compound 
to produce a purple product called Ruhemann’s purple [11-13]. Three 
parameters of the derivatization process were optimized to yield 
the most optimal process and derivative products. We used reaction 
times of 15, 20, and 30 min, temperatures of 70, 80, 90, and 100°C, 
and volumes of ninhydrin of 1 and 2 mL. From our observations, the 
most optimal derivatization process was carried out by mixing 2 mL 
of 200 µg/mL tranexamic acid solution with 1 mL of 1% ninhydrin, 
then heating the solution for 30 min at 90°C using methanol-distilled 
water (90:10, v/v) as the solvent. The reaction time for 30 min was 
considered optimal because it did not show a significant difference 
when the heating process was continued for a few minutes afterward. 
The temperature of 90°C was chosen as the optimal temperature 
because higher temperatures were found to yield more derivative 
products when the temperature increased up to 100°C, it indicated 
that the derivative solution was damaged due to boiling. The volume 
of ninhydrin at 1 mL was chosen because there was a decrease in the 
peak area when the volume of ninhydrin was 2 mL. After a series of 
optimizations, the derivative products were then diluted to obtain the 
desired concentrations. Compared with the previous method by Natesan 
et al. [5], this method was considered simpler and produced more 
stable and precise derivatives during each step of the derivatization.
Optimization of chromatographic conditions
During the optimization of the chromatographic conditions, two 
organic solvents, including methanol and acetonitrile, along with 
various buffers, were used to determine the optimum mobile phase 
combination. From our analyses, it was concluded that the phosphate 
buffer provided better peak shapes than the acetate buffer. This was 
also proven by the previous studies regarding the simultaneous analysis 
of tranexamic acid and mefenamic acid [5]. Optimal chromatographic 
separation was achieved using a UV–visible detector with a wavelength 
of 570 nm, a SunFireTM C18 column (250×4.6 mm, 5 μm), a mobile phase 
of methanol-acetate buffer (20 mM) pH 4.0 (75:25, v/v), and a flow rate 
of 0.8 mL/min. The flow rate of 0.8 mL/min was chosen because it was 
shown to produce the largest peak area with the smallest amount of 
HETP, along with the largest number of theoretical (N) plates. The pH 
of 4 for the buffer was adjusted with acetic glacial acid and was chosen 
according to the pKa of tranexamic acid, which is 4.56 [5]. A slight 
difference in the pH and pKa was expected to maintain the molecular 
form of the tranexamic acid derivatives. In this method, the addition 
of the organic solvents accelerated the retention time of the analyte. 
The use of the mobile phase above produced the largest peak area 
and the shortest retention time compared with other mobile phase 
combinations. The chromatograms of the standard solutions of the 
tranexamic acid derivatives under the optimal analytical conditions are 
shown in Fig. 2, with data from the mobile phase optimization shown 
in Table 1.
System suitability test
The suitability test aimed to ensure that the analytical method was 
not influenced by variations in the existing equipment or the technical 
analysis used, thus the operational system’s effectiveness was 
guaranteed and it provided results that were consistent with the initial 
objectives of the analysis. After six repeated injections, the % RSD for 
the analytical method of the tranexamic acid derivative was 0.33%. 
From the data analysis, the method we developed met the system 
suitability test requirements because it had a % RSD value of no more 
than 2%.
Fig. 1: Structure of tranexamic acid
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Validation method
Selectivity
Selectivity assessment was performed by evaluating the chromatograms 
of the placebo, standard, and cream sample solutions. Based on the 
results of the analysis, the chromatogram of the standard solution had a 
good correlation with the sample, and the chromatogram of the placebo 
solution showed a clean chromatogram with no interference from other 
compounds around the retention time of the tranexamic acid derivative. 
This demonstrated that the placebo cream did not contain compounds 
that could react with ninhydrin; therefore, this method was concluded 
to be selective. The chromatograms for each solution are shown in 
Figs. 2 and 3.
Linearity 
From the six concentrations of the standard solutions in the range of 
8–48 μg/mL, a linear regression equation was obtained, y = 23929x 
+ 8927.1 with a correlation coefficient (r) of 0.9993. From the results 
of the analysis, we considered that the calibration curve had met the 
linearity test requirements. The linear regression data are shown in 
Table 2 and the calibration curve is shown in Fig. 4.
LOD and LOQ
The LOD and LOQ were calculated from the results of the linear 
regression and calibration curves that were obtained. The LOD and LOQ 
were very important because they were used to set the lowest limit of 
Fig. 2: Chromatogram of the tranexamic acid derivative standard
Fig. 3: Chromatogram of a cream sample on the market
Table 1: The results of mobile phase optimization with a flow rate of 1 mL/min




HETP (mm) Theoretical plate (N)
Methanol-20 mM acetic buffer pH 4 75:25 872,658 4.891 1.277 23.572 6364
Acetonitrile-100 mM acetic buffer pH 5 25:75 605,948 11.573 1.277 12.567 11.936
Acetonitrile-10 mM pH 3.6 35:65 471,294 12.851 1.871 23.017 6517
HETP: Height equivalent to a theoretical plate
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the substance concentration that could still be analyzed accurately and 
precisely. Accordingly, a given method is said to be more sensitive if it 
has a smaller LOD and LOQ value. From the results of the analysis, the 
LOD and LOQ obtained were 1.88 μg/mL and 6.25 μg/mL, respectively. 
The full LOD and LOQ sets of data are shown in Table 2.
Recovery and system precision
Recovery was performed to ensure the accuracy and applicability of 
the analytical method. The accuracy and recovery were considered to 
meet the requirements if the values were in the range of 98–102%. 
The recovery was tested at three levels of concentration (80%, 100%, 
and 120%) by the standard addition method. The requirement for 
precision is a % CV ≤ 2% [14]. Based on the experimental results, the 
average recovery percentage obtained for the standard solutions of the 
tranexamic acid derivatives with concentrations of 80%, 100%, and 
120% was 99.93%, 101.06%, and 100.31%. The coefficient variation 
(%CV) values obtained were 0.71, 0.95, and 0.93, respectively. From 
these data, it was concluded that the method for analyzing tranexamic 
acid in cream preparations met the proposed criteria. The complete 
data regarding the accuracy and precision testing are shown in Table 3.
Application of the analytical method to cream samples
This method was optimized for the quantification of tranexamic acid 
in cream samples. The results of the quantification of a whitening 
cream sample on the market showed that the tranexamic acid amount 
contained was 1.08%. This amount does not exceed the set limit for 
cosmetics, which is 1.5–2% [2]. The amount determined was calculated 
based on the linear regression equation obtained from our analysis. 
From the results of the analysis, it was concluded that the method in this 
study was applicable for the analysis of tranexamic acid in whitening 
creams. The quantification data are shown in Table 4.
DISCUSSION
The aim of this study was to develop an efficient and effective analytical 
method for the analysis of tranexamic acid, specifically in cream 
cosmetics. The use of tranexamic acid in cosmetics was proven to be 
as effective as hydroquinone for the treatment of melasma, a common 
disorder characterized by hyperpigmentation of the skin [15]. Therefore, 
valid analytical methods for the analysis of tranexamic acid are 
important to ensure the quality and quantity of tranexamic acid in these 
preparations. Accordingly, the analytical method should be efficient, 
reliable, applicable, fast, and economical. Tranexamic acid does not 
have p-electrons where it could act as a fluorophore or chromophore. 
Hence, it cannot be measured using a UV–visible detector directly and 
derivatization is needed to obtain a chromophore or fluorophore for 
Table 2: Data of the calibration curve, LOD, and LOQ
Concentration (µg/mL) Peak area (µV/s) S (y/x)2 S (y/x) LOD (µg/mL) LOQ (µg/mL)







LOD: Limit of detection, LOQ: Limit of quantification
Table 3: Data obtained from accuracy and precision testing
Real concentration (µg/mL) Counted peak area (µV/s) Counted concentration (µg/mL) SD CV (%) Recovery (%) Average (%)
32 229,117 31.93 0.2280 0.71 99.79 99.93
228,538 32.23 100.70
227,986 31.78 99.30






48 353,489 48.49 0.4458 0.93 101.01 100.31
353,671 47.64 99.26
354,847 48.32 100.67
CV: Coefficient of variation
Table 4: Quantification of tranexamic acid amounts in a whitening cream sample on the market
Sample Sample weight (mg) Peak area (µV/s) Counted concentration (µg/mL) Amount (%) Average amount (%)
X 50 511,156 21.73 1.09 1.08
507,759 21.59 1.08
504,417 21.45 1.07
Fig. 4: Calibration curve of the tranexamic acid derivative
LOD and LOQ
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analysis using an HPLC system with a UV–visible detector. The previous 
studies have reported the analysis of tranexamic acid using HPLC UV 
detection methods and different derivatization reagents, including 
ninhydrin in methanol [5], phenyl isothiocyanate [6], sodium picryl 
sulfonate [8], and 2-hydroxynaphthaldehyde [7]. However, none 
of those studies reported the analysis of tranexamic acid in cream 
formulations. Therefore, in this study, we develop an analytical method 
for analyzing tranexamic acid in cream formulations. Derivatization 
was carried out using a 1% ninhydrin solution in methanol. Ninhydrin 
was selected as the derivative agent because it produced the shortest 
retention time of the derivatives studied and generated a more 
straightforward preparation method compared with other derivatives. 
The derivatization process described here only needs 30 min and is 
a single heating process, thus making it fast and straightforward. In 
addition, the derivatized products were stable during analysis, and the 
total running time was <6 min. The developed method was successfully 
applied for the detection and quantification of tranexamic acid in 
cosmetic cream products.
CONCLUSION
In this study, we developed an economical, simple, fast, and selective 
analytical method for analyzing tranexamic acid in whitening creams 
using RP-HPLC. This method was proven to meet the validation 
requirements, which included selectivity, linearity, LOD and LOQ, 
accuracy, and precision. A precolumn derivatization process using 1% 
ninhydrin was needed to increase the detection of tranexamic acid and 
yielded sharp peaks with a short analysis time of <6 min. This method is 
considered suitable for quality control analysis in industry because it was 
found to be very sensitive and required only a small amount of sample.
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